Aportaciones congreso (1) Publicaciones en las que ha participado algún/a investigador/a

2017

  1. Randomized phase III trial of trastuzumab plus capecitabine with or without pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who experienced disease progression during or after trastuzumab-based therapy

    Journal of Clinical Oncology